Iain J Gallagher
Overview
Explore the profile of Iain J Gallagher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
1694
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Refalo M, Nuckols G, Galpin A, Gallagher I, Hamilton D, Fyfe J
PeerJ
. 2025 Mar;
13:e19042.
PMID: 40028215
Background: Muscle hypertrophy may be influenced by biological differences between males and females. This meta-analysis investigated and changes in muscle size following resistance training (RT) between males and females and...
2.
Deane C, Willis C, Gallagher I, Brook M, Gharahdaghi N, Wylie L, et al.
Transl Exerc Biomed
. 2024 Dec;
1(3-4):277-294.
PMID: 39703532
Objectives: To examine the effect of the NAD precursor, nicotinic acid (NA), for improving skeletal muscle status in sedentary older people. Methods: In a double-blind, randomised, placebo-controlled design, 18 sedentary...
3.
Kuemmerli C, Gallagher I, Skipworth R, Laird B
BMJ Open
. 2024 Aug;
14(8):e089587.
PMID: 39181565
Background: The reporting of randomised controlled non-inferiority (NI) drug trials is poor with less than 50% of published trials reporting a justification of the NI margin. This is despite the...
4.
Paval D, Di Virgilio T, Skipworth R, Gallagher I
Front Oncol
. 2024 Mar;
14:1198555.
PMID: 38482202
Background: Intelectin-1 (ITLN1) is an adipokine with multiple physiological functions, including a role in tumour formation and development. Previous research reported variable ITLN1 levels for cancer patients and healthy individuals....
5.
Macgregor K, Ho F, Celis-Morales C, Pell J, Gallagher I, Moran C
BMC Med
. 2023 Dec;
21(1):488.
PMID: 38066548
Background: Preliminary evidence demonstrates some parameters of metabolic control, including glycaemic control, lipid control and insulin resistance, vary across the menstrual cycle. However, the literature is inconsistent, and the underlying...
6.
Stokes T, Cen H, Kapranov P, Gallagher I, Pitsillides A, Volmar C, et al.
Adv Genet (Hoboken)
. 2023 Jun;
4(2):2200024.
PMID: 37288167
Sequencing the human genome empowers translational medicine, facilitating transcriptome-wide molecular diagnosis, pathway biology, and drug repositioning. Initially, microarrays are used to study the bulk transcriptome; but now short-read RNA sequencing...
7.
Wilson M, Macgregor L, Fyfe J, Hunter A, Hamilton D, Gallagher I
J Sports Sci
. 2022 Jul;
40(15):1700-1711.
PMID: 35852164
Training interventions often have small effects and are tested in small samples. We used a Bayesian approach to examine the change in jump distance after different resistance training programmes. Thirty-three ...
8.
Paval D, Di Virgilio T, Skipworth R, Gallagher I
Front Oncol
. 2022 Feb;
12:767859.
PMID: 35186726
Background: Intelectin (ITLN) is an adipokine with two homologs-ITLN1 and ITLN2-that has various physiological functions. Studies analyzing the relationship between ITLN and cancer are focused on ITLN1; the available literature...
9.
Paval D, Patton R, McDonald J, Skipworth R, Gallagher I, Laird B
J Cachexia Sarcopenia Muscle
. 2022 Jan;
13(2):824-838.
PMID: 35080147
Cancer cachexia is an unmet clinical need that affects more than 50% of patients with cancer. The systemic inflammatory response, which is mediated by a network of cytokines, has an...
10.
Ntikas M, Hunter A, Gallagher I, Di Virgilio T
Front Sports Act Living
. 2021 Dec;
3:737712.
PMID: 34957396
The objective of this study was to assess if injury-related alterations in the Sport Concussion Assessment Tool-5 (SCAT5) are matched by changes in transcranial magnetic stimulation-derived intracortical inhibition. We hypothesised...